Oxolife and its phase II asset OXO-001 for embryo implantation have been featured in the UK’s highest circulated daily newspaper. The Daily Mail calls the endometrium effect of OXO-001 “building a better womb lining nest” which translates into more live birth rates by providing the embryo with the right environment to progress.